UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment

Mayo Clinic proceedings, 2019-08, Vol.94 (8), p.1623-1640

2019

Volltextzugriff (PDF)

Racial disparity in oncologic and quality‐of‐life outcomes in patients with locally advanced head and neck squamous cell carcinomas enrolled in a randomized phase 2 trial

Cancer, 2018-07, Vol.124 (13), p.2841-2849

2018

Volltextzugriff (PDF)

Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patients

Cancer medicine (Malden, MA), 2022-11, Vol.11 (22), p.4104-4111

2022

Volltextzugriff (PDF)

A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache

PloS one, 2015-07, Vol.10 (7), p.e0130733

2015

Volltextzugriff (PDF)

The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma

Blood, 2003-10, Vol.102 (7), p.2562-2567

2003

Volltextzugriff (PDF)

A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer

Clinical cancer research, 2020-02, Vol.26 (4), p.837-845

2020

Volltextzugriff (PDF)

Concurrent cetuximab and postoperative radiation in resected high-risk squamous cell carcinomas of the head and neck: A single-institution experience

Head & neck, 2016-09, Vol.38 (9), p.1318-1323

2016

Volltextzugriff (PDF)

Phase 1 Expansion Cohort of Ramucirumab Plus Pembrolizumab in Advanced Treatment-Naive NSCLC

Journal of thoracic oncology, 2021-02, Vol.16 (2), p.289-298

2021

Volltextzugriff (PDF)

Immunotherapy for Head and Neck Cancer in the Era of Exponentially Increasing Health Care Expenditure

The oncologist (Dayton, Ohio), 2018-02, Vol.23 (2), p.147-149

2018

Volltextzugriff (PDF)

Phase II trial of eribulin mesylate in recurrent or metastatic salivary gland malignancies

Head & neck, 2018-03, Vol.40 (3), p.584-589

2018

Volltextzugriff (PDF)

A phase I study of pazopanib in combination with escalating doses of 131I in patients with well-differentiated thyroid carcinoma borderline refractory to radioiodine

PloS one, 2017-06, Vol.12 (6), p.e0178325-e0178325

2017

Volltextzugriff (PDF)

Ramucirumab in Combination with Pembrolizumab in Treatment-Naïve Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial

Cancers, 2020-10, Vol.12 (10), p.2985

2020

Volltextzugriff (PDF)

Performance status patients

Cancer medicine (Malden, MA), 2022-11, Vol.11 (22), p.4104

2022

Volltextzugriff (PDF)

Treatment options for patients with triple-negative breast cancer

Journal of hematology and oncology, 2010-10, Vol.3 (1), p.42-42, Article 42

2010

Volltextzugriff (PDF)

Predictors of outcome with cetuximab and paclitaxel for head and neck squamous cell carcinoma

The Laryngoscope, 2017-07, Vol.127 (7), p.1583-1588

2017

Volltextzugriff (PDF)

Morbidities of lung cancer surgery in obese patients

The Journal of thoracic and cardiovascular surgery, 2013-08, Vol.146 (2), p.379-384

2013

Volltextzugriff (PDF)

Ramucirumab (R) plus pembrolizumab (P) in treatment naive and previously treated advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: A multi-disease phase I study

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.4046-4046

2017

Volltextzugriff (PDF)

A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS

Blood, 2005-09, Vol.106 (6), p.2156-2161

2005

Volltextzugriff (PDF)

Clinical implication of centrosome amplification in plasma cell neoplasm

Blood, 2006-05, Vol.107 (9), p.3669-3675

2006

Volltextzugriff (PDF)

498 Evorpacept (ALX148), a CD47 myeloid checkpoint inhibitor, in patients with head and neck squamous cell carcinoma (HNSCC) and with gastric/gastroesophageal cancer (GC); ASPEN-01

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A530-A530

2021

Volltextzugriff (PDF)

Prognostic Value of Early Fluorodeoxyglucose-Positron Emission Tomography Response Imaging and Peripheral Immunologic Biomarkers: Substudy of a Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable Non-Small Cell Lung Cancer

Advances in radiation oncology, 2022-03, Vol.7 (2), p.100857, Article 100857

2022

Volltextzugriff (PDF)

Rearrangements and Amplification of IER3 (IEX-1) Represent a Novel and Recurrent Molecular Abnormality in Myelodysplastic Syndromes

Cancer research (Chicago, Ill.), 2009-10, Vol.69 (19), p.7518-7523

2009

Volltextzugriff (PDF)

Chemo and Immuno-Therapeutic Options for Nonsmall Cell Lung Cancer Lung Cancer

The Surgical clinics of North America, 2022-06, Vol.102 (3), p.493-498

Santana-Davila, Rafael

2022

Volltextzugriff (PDF)

Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: Clinicopathologic correlations and new insights from the prelenalidomide era

American journal of hematology, 2008-09, Vol.83 (9), p.708-713

2008

Volltextzugriff (PDF)

1 – 25 von 105

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(90)

Publikationsform

Artikel
(104)
Tagungsberichte
(1)

Sprache

Englisch
(104)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(40)
Life Sciences & Biomedicine
(38)
Humans
(37)
Oncology
(27)
Female
(20)
Male
(20)
Aged
(16)
Middle Aged
(16)
Immunotherapy
(13)
Prognosis
(11)
Adult
(10)
Clinical Trials
(10)
Lung Neoplasms - Drug Therapy
(10)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(9)
Patients
(9)
Aged, 80 And Over
(8)
Chemotherapy
(8)
Hematology
(8)
Metastasis
(8)
Retrospective Studies
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment

Racial disparity in oncologic and quality‐of‐life outcomes in patients with locally advanced head and neck squamous cell carcinomas enrolled in a randomized phase 2 trial

Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patients

A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache

The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma

A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer

Concurrent cetuximab and postoperative radiation in resected high-risk squamous cell carcinomas of the head and neck: A single-institution experience

Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial

Phase 1 Expansion Cohort of Ramucirumab Plus Pembrolizumab in Advanced Treatment-Naive NSCLC

Immunotherapy for Head and Neck Cancer in the Era of Exponentially Increasing Health Care Expenditure

Phase II trial of eribulin mesylate in recurrent or metastatic salivary gland malignancies

A phase I study of pazopanib in combination with escalating doses of 131I in patients with well-differentiated thyroid carcinoma borderline refractory to radioiodine

Ramucirumab in Combination with Pembrolizumab in Treatment-Naïve Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial

Performance status patients

Treatment options for patients with triple-negative breast cancer

Predictors of outcome with cetuximab and paclitaxel for head and neck squamous cell carcinoma

Morbidities of lung cancer surgery in obese patients

Ramucirumab (R) plus pembrolizumab (P) in treatment naive and previously treated advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: A multi-disease phase I study

A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS

Clinical implication of centrosome amplification in plasma cell neoplasm

498 Evorpacept (ALX148), a CD47 myeloid checkpoint inhibitor, in patients with head and neck squamous cell carcinoma (HNSCC) and with gastric/gastroesophageal cancer (GC); ASPEN-01

Prognostic Value of Early Fluorodeoxyglucose-Positron Emission Tomography Response Imaging and Peripheral Immunologic Biomarkers: Substudy of a Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable Non-Small Cell Lung Cancer

Rearrangements and Amplification of IER3 (IEX-1) Represent a Novel and Recurrent Molecular Abnormality in Myelodysplastic Syndromes

Chemo and Immuno-Therapeutic Options for Nonsmall Cell Lung Cancer Lung Cancer

Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: Clinicopathologic correlations and new insights from the prelenalidomide era

Suchergebnisse filtern